Biohit Oyj in Finland resident

Biohit Oyj in Finland resident. Biohit has offices in Germany, France, Britain, Russia, Japan and the USA . In addition, Biohit ‘s products around 450 around 450 distributors in 70 countries. Biohit shares is listed on the NASDAQ OMX Helsinki.

This application of Medidur technology was licensed to Alimera Sciences and is in Phase III clinical trials for the treatment of diabetic macular edema , a potentially blinding disease that affects over 1,000 people in the U.S. The phase III clinical trials were fully enrolled expected over a year ago with preliminary efficacy and safety results in about a year. If approved by the FDA, Alimera under the name under the name IluvienTM.

Into to prevention, diagnosis and treatment of all forms of hearing loss including tinnitus The Deafness Research Germany information services offers free information and advice about the latest scientific knowledge and information by leading experts.

Other Posts From Category "pharmacy":

Related Posts